Atea Pharmaceuticals Inc

NASDAQ:AVIR   3:59:50 PM EDT
8.13
+0.31 (+3.96%)
Earnings Announcements

Atea Pharmaceuticals Provides Clinical And Corporate Update And Reports Third Quarter 2021 Financial Results

Published: 11/11/2021 22:07 GMT
Atea Pharmaceuticals Inc (AVIR) - Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2021 Financial Results.
Qtrly Loss per Share $0.34.
Q3 Earnings per Share View $-0.05 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $75.73 Million
Adjusted EPS is expected to be $0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.72

More details on our Analysts Page.